Can tobacco use cause a false‑positive result on plasma free fractionated metanephrines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tobacco Does NOT Cause False-Positive Plasma Free Fractionated Metanephrines

Tobacco use is not listed as a cause of false-positive results on plasma free fractionated metanephrines testing. The Endocrine Society Clinical Practice Guidelines specifically identify medications and physiological conditions that interfere with metanephrine testing, and tobacco is notably absent from these lists 1.

Known Causes of False-Positive Results

The 2014 Endocrine Society guidelines explicitly identify the following causes of false-positive plasma metanephrine results 1:

Medications That Cause False-Positives:

  • Tricyclic antidepressants (can cause mild to marked elevations, particularly normetanephrine - up to 40% higher with false-positive rates reaching 23%) 2
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs) (similar mechanism to tricyclics) 2
  • Acetaminophen, mesalamine, sulfasalazine (direct interference with LC-ECD measurement methods) 1
  • Midodrine (causes falsely elevated metanephrine through analytical interference) 3
  • Alpha-1 blockers (associated with elevated urinary metanephrines) 4

Physiological Causes:

  • Inappropriate sampling position - seated rather than supine position (most common cause of borderline false-positives) 1
  • Physiological stress - particularly in intensive care settings 1
  • Age - plasma normetanephrine increases with age, accounting for most false-positives in older patients 5

Critical Sampling Requirements

To minimize false-positives, the guidelines emphasize 1:

  • Patient must be fully recumbent (supine) for at least 30 minutes before blood draw
  • Seated sampling increases false-positive likelihood and requires follow-up supine sampling
  • For dopamine metabolite (3-methoxytyramine) measurements, overnight fasting is required

Clinical Approach to Borderline Elevations

When results are borderline positive 1:

  1. First step: Repeat sampling in proper supine position (resolves most false-positives)
  2. If still elevated: Consider clonidine suppression test for normetanephrine
  3. Alternative confirmatory tests: Chromogranin A plus urinary fractionated metanephrines 6
  4. Wait-and-retest approach: For low clinical suspicion, repeat in 6+ months to detect tumor growth patterns

The absence of tobacco from comprehensive lists of interfering substances in authoritative guidelines indicates it does not cause false-positive results on this test.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.